01523nam 2200385 a 450 991070034110332120110517091147.0(CKB)5470000002409577(OCoLC)724459636(EXLCZ)99547000000240957720110517d2010 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierFood and Drug Administration[electronic resource] response to heparin contamination helped protect public health; controls that were needed for working with external entities were recently added : report to the Ranking Member, Committee on Energy and Commerce, House of Representatives[Washington, D.C.] :U.S. Govt. Accountability Office,[2010]1 online resource (iii, 57 pages) illustrationsTitle from PDF title screen (GAO, viewed May 11, 2011)."October 2010.""GAO-11-95."Includes bibliographical references.Food and Drug Administration HeparinDrug adulterationPreventionGovernment policyUnited StatesHeparin.Drug adulterationPreventionGovernment policyUnited States.Congress.House.Committee on Energy and Commerce.GPOGPOBOOK9910700341103321Food and Drug Administration3425941UNINA